StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) income statement

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$5.55+0.12 (+2.21%)

Close on Nov 19, 2026Market cap $37.64MP/E –Yield –

See a number that looks wrong?